Oxford BioDynamics Plc (AIM:OBD)
London · Delayed Price · Currency is GBP · Price in GBX 0.3100
+0.0350 (12.73%)
Feb 12, 2026, 4:23 PM GMT
Oxford BioDynamics Market Cap
Oxford BioDynamics has a market cap or net worth of 13.3 million as of February 12, 2026. Its market cap has increased by 22.80% in one year.
Market Cap
13.30M
Enterprise Value
17.02M
Revenue
1.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.31
Market Cap Chart
Since December 6, 2016, Oxford BioDynamics's market cap has decreased from 136.90M to 13.30M, a decrease of -90.28%. That is a compound annual growth rate of -22.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 11.80M | 27.91% |
| Dec 31, 2025 | 9.23M | 92.61% |
| Dec 31, 2024 | 4.79M | -91.54% |
| Dec 29, 2023 | 56.64M | 125.13% |
| Dec 30, 2022 | 25.16M | -34.45% |
| Dec 31, 2021 | 38.38M | -50.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arecor Therapeutics | 28.70M |
| Aptamer Group | 24.95M |
| Sareum Holdings | 23.47M |
| Fusion Antibodies | 19.38M |
| IXICO | 9.50M |
| Genflow Biosciences | 9.38M |
| OptiBiotix Health | 7.64M |
| Futura Medical | 7.57M |